Are fucoidan and alginate active substances affecting CYP7A1 and HMG CoA reductase in dyslipidemia condition?
Context: Dyslipidemia, characterized by abnormal plasma lipid levels, is commonly treated with statins, which may induce adverse effects. Fucoidan and alginate, bioactive marine polysaccharides, have emerged as potential natural modulators of lipid metabolism via cholesterol 7 alpha-hydroxylase 1 (C...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
GarVal Editorial Ltda.
2026-01-01
|
| Serie: | Journal of Pharmacy & Pharmacognosy Research |
| Soggetti: | |
| Accesso online: | https://jppres.com/jppres/pdf/vol14/jppres_14.1.2388.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|